Live feed09:00:00·224dPRReleasevia QuantisnowAMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025ByQuantisnow·Wall Street's wire, on your screen.AMGN· Amgen Inc.Health Care
